Pharmaceuticals & Biotechnology Editor | 06/12/2012
Rheumatoid Arthritis often starts during the prime of a person’s working life, typically between the age of 35 and 45. Women are 3 times more likely to develop the disease than men. It is an incurable, painful and debilitating auto-immune disease where the body attacks itself, most noticeably in the joints. The total direct and indirect cost of RA in the UK is estimated to cost up to £4.75bn per year. In this video: Leading experts in the treatment of Rheumatoid Arthritis provide an outlin...
To continue reading this story Click Here
RECOMMENDED
MSD announces Phase III data on investigational treatment to lower LDL Cholesterol (LDL-C)
2025-11-17
AI for Pharma & Healthcare 2025
2025-06-18
Upcoming Events
Pharma Contract Manufacturing
23 - 25 March 2026
Mercure Hotel MOA Berlin, Germany
Register Now |
View Agenda |
Learn More